# FDA Inspection 912157 - Trilogy Medical Partners - January 29, 2015

Source: https://www.keypedia.com/records/fda_inspections/trilogy-medical-partners/e3b6b596-b18a-4ee5-9301-72f9eb42e5f7
Source feed: FDA_Inspections

> FDA Inspection 912157 for Trilogy Medical Partners on January 29, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 912157
- Company Name: Trilogy Medical Partners
- Inspection Date: 2015-01-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1281082 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/trilogy-medical-partners/0d88cd06-374c-4fe6-9c73-5f5a28e13439)
- [FDA Inspection 1281082 - 2025-08-20](https://www.keypedia.com/records/fda_inspections/trilogy-medical-partners/ab478f7e-5180-49c2-aa0d-13319fc044fa)
- [FDA Inspection 1006631 - 2017-03-22](https://www.keypedia.com/records/fda_inspections/trilogy-medical-partners/d120866b-143a-4c54-a350-a63a4fa87ed9)

Company: https://www.keypedia.com/companies/trilogy-medical-partners/4eac65fa-f649-4d56-b9ce-5bc89b5b7594

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d